Australia's Little Green Pharma (ASX:LGP) has received Human Research Ethics Approval for a study to support its efforts towards an Australian Schedule 3 cannabidiol...

There's been a lot going on with industrial hemp in the USA since the start of February - here's a summary of some of...

A recent review of studies on cannabidiol (CBD) indicates the non-intoxicating cannabinoid could be of benefit in treating anxiety-related and substance abuse disorders.“This chemical...

A new U.S. national poll has revealed 80% of respondents between the ages of 50 and 80 support allowing medical marijuana if it’s recommended...